Baltimore, MD
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.
rapafusyn.comThese are collections Rapafusyn Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Series A
$28,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Rapafusyn Pharmaceuticals.